Home/Pipeline/CARESTAR Study

CARESTAR Study

Stroke Therapy (Specifics not detailed)

Clinical StudyActive

Key Facts

Indication
Stroke Therapy (Specifics not detailed)
Phase
Clinical Study
Status
Active
Company

About Acandis

Acandis is a privately held medical device company focused on the neurovascular market, specifically stroke treatment. Its core innovation is the HEAL Technology, a proprietary anti-thrombogenic coating designed to improve the integration and safety of intracranial implants like stents and flow diverters. The company has a commercial portfolio of products for stroke care and is actively expanding its reach through distributor networks and clinical studies. Acandis positions itself as an engineering-driven firm aiming to advance stroke prevention and treatment through device miniaturization and biomimetic surface technologies.

View full company profile

Therapeutic Areas